Related Experiment Videos
Pathophysiology of sickle cell anemia
1Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Hematology/Oncology Clinics of North America
|December 1, 1996
Summary
Sickle cell anemia stems from rapid red blood cell destruction and poor red blood cell production. Inhibiting hemoglobin S polymerization and sickling is crucial for managing this complex disease.
Area of Science:
- Hematology
- Molecular Biology
- Pathophysiology
Background:
- Sickle cell anemia (SCA) is characterized by chronic anemia and vaso-occlusive events.
- Red blood cell (RBC) destruction and impaired erythropoiesis are key features of SCA pathophysiology.
Purpose of the Study:
- To elucidate the mechanisms underlying anemia in sickle cell disease (SCD).
- To identify the key factors contributing to early red blood cell destruction and limited erythropoiesis in SCD.
Main Methods:
- Analysis of hemoglobin S (Hb S) polymerization and instability.
- Investigation of red blood cell membrane integrity and cation transport mechanisms.
- Assessment of oxygen affinity in sickle cells (SS cells).
Main Results:
- Markedly shortened circulatory survival of SS cells contributes significantly to anemia.
- Hb S polymerization and oxy-Hb instability lead to early RBC destruction via effects on Hb and cell membranes.
- Low oxygen affinity of SS cells, due to polymer and increased 2,3-DPG, limits erythropoiesis.
- Dense, dehydrated SS cells, including irreversibly sickled cells (ISCs), form rapidly and are critical in disease progression.
Conclusions:
- Anemia in SCD results from combined factors of accelerated RBC destruction and insufficient erythropoiesis.
- Inhibition of Hb S polymerization and sickling is essential for therapeutic strategies, as microvascular occlusion has severe clinical consequences exceeding those of anemia alone.